Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile Marcos Cruces Olivar, Allan D. Burboa, Yolanda M. Gómez

Ranking the importance of their own diseases: A positioning analysis in rheumatic patients and their proxies Aldo Barajas-Ochoa, Elias Kaleb Rojero-Gil, Lilia Patricia Bustamante Montes, Cesar Ramos-Remus

Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study Laura Cano-García, Sara Manrique-Arija, Rocío Redondo-Rodríguez, Marta Vera-Ruiz, Jose Manuel Lisbona-Montañez, Arkaitz Mucientes-Ruiz, Aimara García-Studer, Fernando Ortiz-Marquez, Natalia Mena-Vázquez, Antonio Fernández-Nebro